Neurodegenerative disorders: Advances in neurobiology and new treatment perspectives
Author:
- 30 October 2024
- journal article
- editorial
- Published by Wiley in Basic & Clinical Pharmacology & Toxicology
- Vol. 136 (1)
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Exploring promising minor natural phenolic compounds in neuroprotection‐related preclinical modelsBasic & Clinical Pharmacology & Toxicology, 2024
- A review on the new age methodologies for early detection of Alzheimer's and Parkinson's diseaseBasic & Clinical Pharmacology & Toxicology, 2024
- Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disordersBasic & Clinical Pharmacology & Toxicology, 2024
- Dementia and depression: Biological connections with amyloid β proteinBasic & Clinical Pharmacology & Toxicology, 2024
- Perineuronal nets as regulators of parvalbumin interneuron function: Factors implicated in their formation and degradationBasic & Clinical Pharmacology & Toxicology, 2024
- The role of ATP‐binding cassette transporter G1 (ABCG1) in Alzheimer's disease: A review of the mechanismsBasic & Clinical Pharmacology & Toxicology, 2024
- The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β‐evoked neurotoxicity and changes in cell morphology in PC12 cellsBasic & Clinical Pharmacology & Toxicology, 2023
- Hallmarks of neurodegenerative diseasesCell, 2023
- Neurodegenerative disease of the brain: a survey of interdisciplinary approachesJournal of The Royal Society Interface, 2023
- The changing prevalence and incidence of dementia over time — current evidenceNature Reviews Neurology, 2017